ÂÜÀòÂÒÂ×

Angela Beaulieu is an experienced professional in process development and engineering, currently serving as Associate Director at Sail Biomedicines since October 2022, where Angela leads a team focused on optimizing drug product processes. Previously, Angela held the role of Director of Process and Product Development Operations at bioX, managing laboratory-based projects and overseeing a team, and served as a Process Development Engineer at Translate Bio, leading LNP process scale-up. Angela’s extensive background includes positions at Kaleido Biosciences, Ocular Therapeutix, BIND Therapeutics, and the Polymer Research Group, contributing to various aspects of manufacturing and process optimization. Angela holds a Master of Engineering in Engineering/Industrial Management from Tufts University and dual Bachelor of Science degrees in Chemical Engineering from the University of New Hampshire.